• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕利哌酮治疗氯胺酮诱导的精神病:病例报告。

Paliperidone for the treatment of ketamine-induced psychosis: a case report.

机构信息

University of Genoa, Italy.

"San Paolo" Hospital, Savona, Italy.

出版信息

Int J Psychiatry Med. 2014;48(2):103-8. doi: 10.2190/PM.48.2.c.

DOI:10.2190/PM.48.2.c
PMID:25377151
Abstract

Ketamine is an anaesthetic and analgesic drug synthesized in the 1960s from phencyclidine. The recreational use of ketamine increased among the dance culture of techno and house music, in particular in clubs, discotheques, and rave parties. The psychotropic effects of ketamine are now well known and they range from dissociation to positive, negative, and cognitive schizophrenia-like symptoms. We report a case of a chronic oral consumption of ketamine which induced agitation, behavioral abnormalities, and loss of contact with reality in a poly-drug abuser; these symptoms persisted more than two weeks after the drug consumption had stopped. Antipsychotic treatment with paliperidone led to a successful management of the psychosis, getting a complete resolution of the clinical picture. Paliperidone has proven to be very effective in the treatment of ketamine-induced disorders. Moreover, the pharmacological action and metabolism of paliperidone are poorly dependent from the activity of liver enzymes, so that it seems to be one of the best second generation antipsychotics for the treatment of smokers and alcohol abusers.

摘要

氯胺酮是一种 20 世纪 60 年代从苯环己哌啶合成的麻醉和镇痛药物。氯胺酮在科技和浩室音乐的舞蹈文化中,特别是在俱乐部、迪斯科舞厅和锐舞派对中,被滥用于娱乐。氯胺酮的精神作用现在已经广为人知,其范围从分离到积极、消极和认知性精神分裂症样症状。我们报告了一例慢性口服氯胺酮的病例,该病例导致一名多药滥用者出现激动、行为异常和与现实失去联系;这些症状在药物停止使用后持续了两周以上。使用帕利哌酮进行抗精神病治疗成功地控制了精神病,完全解决了临床症状。帕利哌酮已被证明对治疗氯胺酮引起的疾病非常有效。此外,帕利哌酮的药理作用和代谢与肝酶的活性关系不大,因此它似乎是治疗吸烟者和酗酒者的最佳第二代抗精神病药物之一。

相似文献

1
Paliperidone for the treatment of ketamine-induced psychosis: a case report.帕利哌酮治疗氯胺酮诱导的精神病:病例报告。
Int J Psychiatry Med. 2014;48(2):103-8. doi: 10.2190/PM.48.2.c.
2
Improvement of phencyclidine-associated psychosis with ECT.
J Clin Psychiatry. 1986 Sep;47(9):477-8.
3
Efficacy and safety of paliperidone extended-release tablets: results of a 6-week, randomized, placebo-controlled study.帕利哌酮缓释片的疗效与安全性:一项为期6周的随机、安慰剂对照研究结果
Biol Psychiatry. 2007 Dec 15;62(12):1363-70. doi: 10.1016/j.biopsych.2007.01.017. Epub 2007 Jun 28.
4
Effects of ketamine in normal and schizophrenic volunteers.氯胺酮对正常和精神分裂症志愿者的影响。
Neuropsychopharmacology. 2001 Oct;25(4):455-67. doi: 10.1016/S0893-133X(01)00243-3.
5
Measuring social functioning with the personal and social performance scale in patients with acute symptoms of schizophrenia: interpretation of results of a pooled analysis of three Phase III trials of paliperidone extended-release tablets.用个人和社会表现量表测量处于精神分裂症急性期患者的社会功能:帕利哌酮缓释片三项 III 期临床试验汇总分析结果的解读。
Clin Ther. 2010 Feb;32(2):275-92. doi: 10.1016/j.clinthera.2010.02.003.
6
A double-blind, placebo-controlled, randomized study evaluating the effect of paliperidone extended-release tablets on sleep architecture in patients with schizophrenia.一项双盲、安慰剂对照、随机研究,评估帕利哌酮缓释片对精神分裂症患者睡眠结构的影响。
Int Clin Psychopharmacol. 2007 Sep;22(5):299-308. doi: 10.1097/YIC.0b013e3281c55f4f.
7
Psychopathological and auditory evoked potential correlates of ketamine psychosis--a single case report.氯胺酮所致精神病的精神病理学与听觉诱发电位相关性——一例报告
Schizophr Res. 2000 Jan 21;41(2):386-8.
8
Reserpine and phencyclidine-associated psychosis: three case reports.
J Clin Psychiatry. 1985 Dec;46(12):542-4.
9
The efficacy of ECT in phencyclidine-induced psychosis.电休克疗法治疗苯环利定所致精神病的疗效。
J Clin Psychiatry. 1984 May;45(5):220-2.
10
Paliperidone extended-release tablets in patients with recently diagnosed schizophrenia.帕利哌酮长效片治疗近期诊断为精神分裂症的患者。
Early Interv Psychiatry. 2010 Feb;4(1):64-78. doi: 10.1111/j.1751-7893.2010.00165.x.

引用本文的文献

1
Head-to-head comparison of 1-year aripiprazole long-acting injectable (LAI) versus paliperidone LAI in comorbid psychosis and substance use disorder: impact on clinical status, substance craving, and quality of life.阿立哌唑长效注射剂(LAI)与帕利哌酮LAI治疗合并精神病和物质使用障碍的1年疗效对比:对临床状态、物质渴望及生活质量的影响
Neuropsychiatr Dis Treat. 2018 Jun 21;14:1645-1656. doi: 10.2147/NDT.S171002. eCollection 2018.
2
Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Chronic Pain From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists.美国区域麻醉和疼痛医学学会、美国疼痛医学学会和美国麻醉师学会关于静脉注射氯胺酮输注治疗慢性疼痛的共识指南。
Reg Anesth Pain Med. 2018 Jul;43(5):521-546. doi: 10.1097/AAP.0000000000000808.
3
Oral Ketamine in Treatment-Resistant Depression: A Clinical Effectiveness Case Series.口服氯胺酮治疗难治性抑郁症:临床疗效病例系列
J Clin Psychopharmacol. 2017 Aug;37(4):464-467. doi: 10.1097/JCP.0000000000000717.